2023
DOI: 10.1208/s12248-023-00869-4
|View full text |Cite
|
Sign up to set email alerts
|

Tuning the Emulsion Properties Influences the Size of Poly(Caprolactone) Particles for Drug Delivery Applications

Ashbey N. Manning,
Claire E. Rowlands,
Hope Saindon
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…8 In addition to the EPR effect, naparticle formulations mitigate limitations in bioavailbility, solubility, and absorption compared with free drug. 9,10 A common way to create these nanoformulations is to encapsulate the drug in a polymeric nanoparticle. These formulations can be commonly referred to as drug delivery systems (DDSs).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…8 In addition to the EPR effect, naparticle formulations mitigate limitations in bioavailbility, solubility, and absorption compared with free drug. 9,10 A common way to create these nanoformulations is to encapsulate the drug in a polymeric nanoparticle. These formulations can be commonly referred to as drug delivery systems (DDSs).…”
Section: Introductionmentioning
confidence: 99%
“…12 Although not as common for DDS as some of its other aliphatic polyester counterparts such as poly(lactic-co-glycolic acid) (PLGA) or poly(lactic acid) (PLA), it remains a promising polymer for drug delivery due to being highly tunable with diffusion dominating short-term drug release as well as low production cost. 9 Creating Paclitaxel loaded PCL nanoparticles will reduce the current limitations of free Paclitaxel such as its low solubility which will create a more effective treatment option. 13,14…”
Section: Introductionmentioning
confidence: 99%